ADC Therapeutics
ADCT
#7499
Rank
โ‚ฌ0.35 B
Marketcap
2,83ย โ‚ฌ
Share price
-7.06%
Change (1 day)
55.79%
Change (1 year)

Revenue for ADC Therapeutics (ADCT)

Revenue in 2025 (TTM): โ‚ฌ67.51 Million

According to ADC Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ64.59 Million. In 2024 the company made a revenue of โ‚ฌ68.07 Million an increase over the revenue in the year 2023 that were of โ‚ฌ62.92 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ADC Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ67.51 M-0.81%
2024 โ‚ฌ68.07 M8.18%
2023 โ‚ฌ62.92 M-67.85%
2022 โ‚ฌ0.19 B553.41%
2021 โ‚ฌ29.94 M
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA